Complementary DNA sequence of the novel HLA-B*3704 allele

Tissue Antigens. 2002 Feb;59(2):142-4. doi: 10.1034/j.1399-0039.2002.590213.x.

Abstract

The novel HLA-B*3704 allele was identified by polymerase chain reaction with sequence specific oligoneucletides (PCR-SSO) in a Spanish Caucasoid individual whose T-lymphocytes showed an ambiguous HLA-B phenotype. The nucleotide sequence of B*3704 was determined after reverse transcription-polymerase chain reaction (RT-PCR) amplification and molecular cloning of its complete coding region. B*3704 differs from B*3701 by a single nucleotide replacement that induces the substitution of histidine for tyrosine 171. Residue 171 is located in the alpha-helix of the alpha-2 domain, lining the A pocket of the peptide-binding site. Therefore, the His171 substitution seen in HLA-B*3704 is likely to affect its antigen-presenting properties and is probably responsible for the differentiated serological phenotype of this allele in comparison with B*3701.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles*
  • Base Sequence
  • Cloning, Molecular
  • DNA, Complementary
  • HLA-B Antigens / genetics*
  • HLA-B Antigens / immunology
  • HLA-B37 Antigen
  • Humans
  • Molecular Sequence Data
  • Polymorphism, Genetic
  • Protein Structure, Secondary
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sequence Analysis, DNA
  • Sequence Homology, Nucleic Acid
  • White People / genetics

Substances

  • DNA, Complementary
  • HLA-B Antigens
  • HLA-B37 Antigen